Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
88.99
-1.25 (-1.39%)
At close: Apr 28, 2026, 4:00 PM EDT
88.50
-0.49 (-0.55%)
After-hours: Apr 28, 2026, 7:39 PM EDT
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $854.82 million as of April 28, 2026. Its market cap has increased by 228.89% in one year.
Market Cap
854.82M
Enterprise Value
789.79M
1-Year Change
228.89%
Ranking
Category
Stock Price
$88.99
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $854.82M, an increase of 1,945.85%. That is a compound annual growth rate of 78.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 873.45M | 39.27% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phathom Pharmaceuticals | 907.89M |
| LB Pharmaceuticals | 903.86M |
| CytomX Therapeutics | 894.72M |
| Janux Therapeutics | 877.80M |
| Xencor | 874.93M |
| SELLAS Life Sciences Group | 869.18M |
| Theravance Biopharma | 863.54M |
| MannKind | 863.08M |